Skip to Main Content

Paper Details

A screen for MeCP2-TBL1 interaction inhibitors using a luminescence-based assay.
Sci Rep
1
2023
MDS, MeCP2, MeCP2 duplication, MeCP2 duplication syndrome, NCoR, NanoLuc luciferase, PKA, TBL1, TBLR1, autism spectrum disorder, chromatin, luciferase, methylated, methylated DNA, neurodevelopmental disorders, neuronal dysfunction, nuclear co-repressor, protein kinase A
Author NameAffiliation
Almer M van der SlootInstitute for Research in Immunology and Cancer (IRIC), Universite de Montreal
Almer M van der SlootMila - Quebec Artificial Intelligence Institute
Mike TyersInstitute for Research in Immunology and Cancer (IRIC), Universite de Montreal
Mike TyersThe Hospital for Sick Children Research Institute
Mike TyersUniversity of Toronto
Mike TyersInstitute for Research in Immunology and Cancer (IRIC), Universite de Montreal
Mike TyersThe Hospital for Sick Children Research Institute
Mike TyersUniversity of Toronto
  • 1 - 8

Datasets

Release 1.2